Latisse
FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks »
"Today, the U.S. Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.
Accordin"...
Read the FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks article »
Latisse
INDICATIONS
LATISSE® (bimatoprost) ophthalmic solution 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
DOSAGE AND ADMINISTRATION
Ensure the face is clean, makeup and contact lenses are removed. Once nightly, place one drop of LATISSE® (bimatoprost ophthalmic solution) 0.03% on the disposable sterile applicator supplied with the package and apply evenly along the skin of the upper eyelid margin at the base of the eyelashes. The upper lid margin in the area of lash growth should feel lightly moist without runoff. Blot any excess solution runoff outside the upper eyelid margin with a tissue or other absorbent cloth. Dispose of the applicator after one use. Repeat for the opposite eyelid margin using a new sterile applicator.
Do not reuse applicators and do not use any other brush/applicator to apply LATISSE®.
Do not apply to the lower eyelash line [see WARNINGS AND PRECAUTIONS and PATIENT INFORMATION].
Additional applications of LATISSE® will not increase the growth of eyelashes.
Upon discontinuation of treatment, eyelash growth is expected to return to its pre-treatment level.
HOW SUPPLIED
Dosage Forms And Strengths
Bimatoprost ophthalmic solution 0.3 mg/mL.
Storage And Handling
LATISSE™ (bimatoprost ophthalmic solution) 0.03% is supplied sterile in opaque white low density polyethylene dispenser bottles and tips with turquoise polystyrene caps accompanied by sterile, disposable applicators:
1.5 mL in a 5 mL bottle with 40 applicators NDC 0023-3616-15
3 mL in a 5 mL bottle with 70 applicators NDC 0023-3616-70
5 mL in a 5 mL bottle with 140 applicators NDC 0023-3616-05
Storage
LATISSE® should be stored at 2- 25°C (36-77°F).
Allergan, Inc., Irvine, CA 92612. Revised: 03/2013
Last reviewed on RxList: 4/8/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Latisse Information
Latisse - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Skin & Beauty
Get beauty tips and body treatments.






